Literature DB >> 8389470

Metabolic labeling of mitogen-activated protein kinase kinase in A431 cells demonstrates phosphorylation on serine and threonine residues.

N G Ahn1, J S Campbell, R Seger, A L Jensen, L M Graves, E G Krebs.   

Abstract

Mitogen-activated protein (MAP) kinase kinase is an enzyme that activates the growth factor-regulated MAP kinase in vitro by a mechanism that involves direct phosphorylation of MAP kinase on tyrosine and threonine residues. MAP kinase kinase is stimulated by growth factor treatment of cells and has been shown to be inactivated with protein phosphatases, suggesting that it is regulated by protein phosphorylation. Analysis of two epidermal growth factor-stimulated forms of MAP kinase kinase, purified from 32P-labeled A431 cells, shows that the kinase is phosphorylated on serine and threonine residues and that treatment with protein phosphatases leads to serine dephosphorylation. Under conditions that lead to complete inactivation, only partial dephosphorylation of MAP kinase kinase is observed. Consistent with this finding, inactive forms of MAP kinase kinase, which separate from active forms during the course of purification, are also observed to be phosphorylated in intact cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389470      PMCID: PMC46671          DOI: 10.1073/pnas.90.11.5143

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Activation of the MAP kinase pathway by the protein kinase raf.

Authors:  L R Howe; S J Leevers; N Gómez; S Nakielny; P Cohen; C J Marshall
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

2.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product.

Authors:  C M Crews; A Alessandrini; R L Erikson
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

Review 3.  The mitogen-activated protein kinase activator.

Authors:  N G Ahn; R Seger; E G Krebs
Journal:  Curr Opin Cell Biol       Date:  1992-12       Impact factor: 8.382

4.  Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase.

Authors:  J Wu; J K Harrison; L A Vincent; C Haystead; T A Haystead; H Michel; D F Hunt; K R Lynch; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

5.  Human T-cell mitogen-activated protein kinase kinases are related to yeast signal transduction kinases.

Authors:  R Seger; D Seger; F J Lozeman; N G Ahn; L M Graves; J S Campbell; L Ericsson; M Harrylock; A M Jensen; E G Krebs
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

6.  Raf-1 activates MAP kinase-kinase.

Authors:  J M Kyriakis; H App; X F Zhang; P Banerjee; D L Brautigan; U R Rapp; J Avruch
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

7.  Involvement of MAP kinase activators in angiotensin II-induced activation of MAP kinases in cultured vascular smooth muscle cells.

Authors:  Y Ishida; Y Kawahara; T Tsuda; M Koide; M Yokoyama
Journal:  FEBS Lett       Date:  1992-09-21       Impact factor: 4.124

8.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro.

Authors:  P Dent; W Haser; T A Haystead; L A Vincent; T M Roberts; T W Sturgill
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

9.  The amino acid sequence of a mammalian MAP kinase kinase.

Authors:  A Ashworth; S Nakielny; P Cohen; C Marshall
Journal:  Oncogene       Date:  1992-12       Impact factor: 9.867

10.  Xenopus MAP kinase activator is a serine/threonine/tyrosine kinase activated by threonine phosphorylation.

Authors:  H Kosako; Y Gotoh; S Matsuda; M Ishikawa; E Nishida
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  11 in total

1.  Differential effect of glucose deprivation on MAPK activation in drug sensitive human breast carcinoma MCF-7 and multidrug resistant MCF-7/ADR cells.

Authors:  A K Gupta; Y J Lee; S S Galoforo; C M Berns; A A Martinez; P M Corry; X Wu; K L Guan
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

2.  Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation.

Authors:  W Huang; A Alessandrini; C M Crews; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

3.  Constitutive activation of Mek1 by mutation of serine phosphorylation sites.

Authors:  W Huang; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Biochemical and biological analysis of Mek1 phosphorylation site mutants.

Authors:  W Huang; D S Kessler; R L Erikson
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

Review 5.  The MAP kinase cascade. Discovery of a new signal transduction pathway.

Authors:  N G Ahn
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

6.  Protein kinase A acts at multiple points to inhibit Xenopus oocyte maturation.

Authors:  W Matten; I Daar; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

7.  Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.

Authors:  F Romerio; A Riva; D Zella
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

8.  Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1).

Authors:  G Pagès; A Brunet; G L'Allemain; J Pouysségur
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

9.  Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.

Authors:  C F Zheng; K L Guan
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

10.  Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.

Authors:  D R Alessi; Y Saito; D G Campbell; P Cohen; G Sithanandam; U Rapp; A Ashworth; C J Marshall; S Cowley
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.